ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Gastroenterology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,536Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 832

$670K Total Retail Price of All Prescriptions

Rank: 16 out of 832

703 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 703 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

3% of this provider’s 9,446 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 35%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $129 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 5.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 717 567 1 1
ATORVASTATIN CALCIUM 575 504 2 10
LEVOTHYROXINE SODIUM 554 527 3 11
AMLODIPINE BESYLATE 432 375 4 7
LISINOPRIL 432 345 4 13
ATENOLOL 424 359 6 22
CRESTOR 372 318 7 32
HYDROCHLOROTHIAZIDE 287 242 8 21
DIOVAN 280 232 9 36
METFORMIN HCL 228 180 10 20
GLYBURIDE 208 179 R 11 65
FUROSEMIDE 207 194 12 15
SIMVASTATIN 185 143 13 4
HYDRALAZINE HCL 170 144 14 85
METOCLOPRAMIDE HCL 167 56 15 27
AMLODIPINE BESYLATE-BENAZEPRIL 161 145 16 71
ONDANSETRON HCL 153 133 17 125
PANTOPRAZOLE SODIUM 150 135 18 3
CLONIDINE HCL 149 121 19 110
PRAVASTATIN SODIUM 146 126 20 67
HYDROCODONE-ACETAMINOPHEN 143 93 S3 21 75
METOPROLOL TARTRATE 139 139 22 19
WARFARIN SODIUM 136 114 23 30
SYNTHROID 133 126 24 42
ZETIA 123 113 25 66
SUPREP 120 105 26 28
LOSARTAN POTASSIUM 113 94 27 25
AZITHROMYCIN 109 94 28 49
METOPROLOL SUCCINATE 106 83 29 17
LOVASTATIN 100 88 30 74
NEXIUM 96 44 31 2
GEMFIBROZIL 91 81 32 175
ASACOL 90 66 33 46
RAMIPRIL 90 80 33 51
ZOLPIDEM TARTRATE 79 78 35 18
CLOPIDOGREL 79 72 35 54
ALLOPURINOL 75 73 37 57
EXFORGE 70 51 38 191
GABAPENTIN 67 45 39 47
ISOSORBIDE MONONITRATE ER 66 51 40 86
CARVEDILOL 65 53 41 72
KLOR-CON M20 64 64 42 145
BISOPROLOL-HYDROCHLOROTHIAZIDE 61 61 43 206
METHYLDOPA 61 58 R 43 206
PEG-3350 AND ELECTROLYTES 59 24 45 58
LOVAZA 59 42 45 63
BENAZEPRIL HCL 58 58 47 165
KLOR-CON M10 57 52 48 217
LEVOXYL 56 53 49 219
JANUVIA 55 49 50 53
DIOVAN HCT 54 48 51 70
TAMSULOSIN HCL 53 53 52 45
GLYBURIDE-METFORMIN HCL 53 53 R 52 84
AMITIZA 51 25 54 24
PREDNISONE 51 20 54 105
SERTRALINE HCL 51 50 54 61
NIASPAN 51 42 54 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.